Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Exxon Mobil | 3.46% | $1.31B | $583.66B | 30.71% | 74 Outperform | |
| Johnson & Johnson | 3.20% | $1.21B | $555.94B | 51.87% | 78 Outperform | |
| JPMorgan Chase | 2.78% | $1.05B | $838.84B | 17.51% | 72 Outperform | |
| Apple | 2.70% | $1.02B | $3.96T | 15.76% | 79 Outperform | |
| AbbVie | 2.59% | $978.05M | $398.79B | 18.80% | 66 Neutral | |
| Procter & Gamble | 2.45% | $925.99M | $356.01B | -7.62% | 69 Neutral | |
| Philip Morris | 2.41% | $911.26M | $280.10B | 35.75% | 61 Neutral | |
| Microsoft | 2.39% | $903.12M | $3.14T | -0.28% | 79 Outperform | |
| Home Depot | 2.20% | $831.56M | $376.42B | -7.38% | 66 Neutral | |
| Merck & Company | 2.08% | $786.22M | $281.39B | 27.66% | 80 Outperform |